Genzyme rejected Sanofi-Aventis' $18.5 billion buyout offer, the New York Times reports.
Genzyme rejected Sanofi-Aventis' $18.5 billion buyout offer, the New York Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.